Clinical Trial Comparing Standard Wound Closure Techniques Versus TissuGlu® Surgical Adhesive

Inclusion Criteria: * Male or female, ≥ 18 years of age * Provide signed and dated informed consent form * Willing to comply with all study procedures, schedules and be available for the follow-up evaluations for the duration of the study * Willing to follow instructions for incision and drain care, and follow guidelines related to resumption of daily activities * Agree not to schedule any additional elective surgical procedures that involve an incision until their participation in the study is complete * In good general health in the opinion of the Investigator with no conditions that would significantly impact wound healing as determined by medical history, and review of recent concomitant medications * Requiring at least one full thickness surgical incision of at least 20cm in length as part of elective abdominoplasty * ≤ ASA2 - American Society of Anesthesiologists Physical Classification System (2=subject with mild systemic disease) * Have a Body Mass Index (BMI) ≤ 28 Exclusion Criteria: * Pregnancy or lactation * Previous abdominoplasty * Prior bariatric or weight loss surgery * Lost ≥ 15% of maximum lifetime bodyweight (excluding pregnancy weight gain) * Known medical condition that results in compromised blood supply to tissues * Have known or suspected allergy or sensitivity to any test materials or reagents * Have severe co-morbid conditions (e.g., heart disease) * Are currently a smoker or have smoked within 30 days of prescreening as determined by nicotine test * Any condition known to effect wound healing, such as collagen vascular disease * Be known to have a blood clotting disorder and/or be willing to discontinue anti-coagulation therapy including aspirin * Diagnosis of diabetes with current medical treatment * Receiving antibiotic therapy for pre-existing condition or infection * Have known personal or family history of keloid formation or hypertrophic scarring * Currently taking systemic steroids or immunosuppressive agents * Undergoing concurrent adjacent or congruent Liposuction agents * Use of pain pumps after the abdominoplasty procedure * Concurrent use of fibrin sealants or other internal wound care devices * Concurrent hernia repair greater than 6 cm and/or requiring the use of mesh * Mini abdominoplasty (abdominoplasty without umbilical transposition) * Be participating in any current clinical trial or have participated in any clinical trial within 30 days of enrollment in this study